Assessment on regional myocardial mechanics of left ventricle in patients with liver cirrhosis using three-dimensional strain parameters

Abstract

Abstract: Objective To evaluate myocardial mechanics of left ventricle in patients with early-stage liver cirrhosis using three-dimensional echocardiographic strain parameters, and to explore effective ultrasonic parameters for diagnosis of cirrhotic cardiomyopathy.Methods Twenty-eight healthy volunteer were enrolled as controls (group A), and 25 early-stage cirrhotic patients were enrolled in group B. Three-dimensional speckle tracking imaging (3D-STI) were applied to analyze global 3-D strain (G3DS), global longitudinal strain (GLS) and area strain dyssynchrony index (ASDI) of left ventricle. Meanwhile, left ventricular ejection fraction (LVEF),left ventricular end-diastolic volume (LVEDV) and early diastolic wave/atrial contractive wave (E/A) ratio of mitral flow were measured using conventional ultrasound. Results Compared with those in group A, G3DS, GLS and E/A ratio in group B were significantly decreased (P<0.05), while ASDI was significantly increased (P<0.05). Additionally, levels of LVEDV and LVEF in group B showed no significant difference with that in group A (P<0.05). Conclusion Three-dimensional echocardiographic strain parameters could effectively evaluate left ventricular myocardial systolic dysfunction induced by early-stage liver cirrhosis.

Key words: Echocardiography, Liver cirrhosis, Left ventricular, Strain, Three dimensional

QIAN Rong,XIONG Ai-min,YANG Wei-zhong,WANG Xiu-mei,LIU Ping,LIU Wen-jie, CHEN Ting-ting,ZHOU Zhu,XIE Yan-chun,KE Jing-jing,LI Jing,XU Xiao-ting,YANG Jun.. Assessment on regional myocardial mechanics of left ventricle in patients with liver cirrhosis using three-dimensional strain parameters[J]. Chinese Hepatolgy, 2017, 22(4): 320-322.

References 8

[1]	Wong F. Cirrhotic cardiomyopathy. J Hepatol Int,2009,3:294-304.
[2]	Seo Y, Ishizu T,Atsumi A,et al.Three-dimensional speckle tracking echocardiography. Cire J,2014,78: 1290-1301.
[3]	Brondex A, Arles F,Lipovac AS,et al.Cirrhotic cardiomyopathy:a specific entity. Ann Cardiol Angeiol (Paris),2012,61:99-104.
[4]	Therapondos G,Flapan AD,Plevris JN,et al.Cardiac morbidity and mortality related to orthotopic liver transplantation.Liver Transpl,2004,10:1441-1453.
[5]	Hong QL,Seyed AG,Samuel SL. Cardiac and vascular changes in cirrhosis:pathogenic mechanisms.World J Castroenterol,2006,12:837-842.
[6]	毛华,江登丰,黄纯炽,等.肝硬化患者心功能改变及其影响因素.广东医学,2012,14:2149-2152.
[7]	Hayat D,Kloeckner M,Nahum J,et al.Comparison of real-time three-dimensional speckle tracking to magnetic resonance imaging in patients with coronary heart disease.Am J Cardiol,2012,109:180-186.
[8]	Wang J, Fang F, Yip GW, et al. Importance of chronotropic response and left ventricular long-axis function for exercise performance in patients with heart failure and preserved ejection fraction.Int J Cardiol,2015, 202:339-343.

[1]	LI Xiu-lan, LIU Qing, RAN Ran. Clinical observation of hysteroscopic surgery in patients with decompensated liver cirrhosis [J]. Chinese Hepatolgy, 2020, 25(4): 365-368.
[2]	HU Hua-hua, LIU Jun, GUAN Li-yu, XU Jie-hong, YI Hong, LI Zhong-zhuan, QIN Shu-fen, DENG Xiang-yu. Hemodynamic analysis of liver cirrhosis complicated with esophageal and gastric varices rupture [J]. Chinese Hepatolgy, 2020, 25(4): 369-371.
[3]	ZHUANG Yan, LU Jie, XIE Qing, LIN Lan-yi.. Study on the current status of Direct-acting antiviral Treatment in Chinese patients with HCV-related liver cirrhosis [J]. Chinese Hepatolgy, 2020, 25(3): 249-253.
[4]	KONG Yuan-yuan, WEI Wei, SHAN Shan, MA Hong, OU Xiao-juan, XU Xiao-yuan, DUAN Zhong-ping, HOU Jin-lin, WEI Lai, YOU Hong, JIA Ji-dong, CR-HepB Group. Clinical profiles and treatment patterns of patients with HBV-related liver cirrhosis [J]. Chinese Hepatolgy, 2020, 25(2): 123-127.
[5]	MENG Qing-yang, XU Chun-lin, KANG Peng. Ox-LDL-induced ETs production of macrophages in patients with cirrhosis [J]. Chinese Hepatolgy, 2019, 24(9): 1007-1010.
[6]	XU Qiang, MA Yan, GUO Feng, WANG Xiao-bo, WANG Xiao-zhong. Analysis of risk factors for 30-day death of cirrhosis-associated acute kidney injury [J]. Chinese Hepatolgy, 2019, 24(8): 857-860.
[7]	QIAN Rong, YANG Wei-zhong. Evaluation the hemodynamics of middle cerebral artery in patients with liver cirrhosis by transcranial Doppler ultrasound combined with breath-holding test [J]. Chinese Hepatolgy, 2019, 24(8): 861-863.
[8]	SHU Dan, HUANG Xiang-rong, JIANG Yu-jin, HUANG Ting, LIU Ying-xia, XU Cheng.. Logistic regression analysis of risk factors for portal vein thrombosis in liver cirrhosis [J]. Chinese Hepatolgy, 2019, 24(7): 740-743.
[9]	ZHANG Jun-chang, XU Biao, KUANG Zhi-dan, MOU Jin-song. Efficacy analysis of ascites drainage in 25 patients with liver cirrhosis complicated with intra-abdominal hypertension under bladder pressure monitoring [J]. Chinese Hepatolgy, 2019, 24(5): 497-498.
[10]	HU Xing, MENG Fan-kun, HAN Jing, ZUO Qiao. Evaluation of the cardiac function in patients with liver cirrhosis by tissue Doppleimag Tei index [J]. Chinese Hepatolgy, 2019, 24(3): 239-242.
[11]	WANG Dan, MU Jin-song, HU Zhi-jun, YAN Bing-bing, KUANG Zhi-dan. Prognostic risk factors in patients with cirrhosis and cerebral hemorrhage [J]. Chinese Hepatolgy, 2019, 24(10): 1116-1118.
[12]	ZHANG Zhen, WANG Meng-long, ZHANG Hai-tao, ZHANG Qi-kun, LIU Fu-quan. Risk factors for early portal venous system thrombosis after devascularization with splenectomy and portal hypertension in cirrhotic patients with portal hypertension and preventive effects of blood activating, anticoagulation and antiplatelet therapy [J]. Chinese Hepatolgy, 2019, 24(1): 24-27.
[13]	YIN Wei, LI Cheng-zhong, ZOU Duo-wu. Influence of liver function on the outcomes and prognosis of acute kidney injury in liver cirrhosis and liver failure patients [J]. Chinese Hepatolgy, 2018, 23(4): 297-301.
[14]	XIONG Jing-ping, LIU Hai-ying, ZHANG Yue-xin. Analysis of risk factors for portal vein thrombosis in liver cirrhosis patients [J]. Chinese Hepatolgy, 2018, 23(3): 206-209.
[15]	LIN Yi-jun, MA Jia-li, ZHOU Yu-lin, HU Ju-long, LIANG Xiu-xia, LI Ping.. Helicobacter pylori infection as a protective factor for glue extrusion bleeding [J]. Chinese Hepatolgy, 2018, 23(2): 118-120.